BioNTech to acquire German rival CureVac in a $1.25B all-stock deal, bolstering its mRNA capabilities.
UK economy contracts in April due to tariff impact, raising concerns over growth and government targets.
U.S. Health Secretary Robert F. Kennedy Jr. dismisses CDC vaccine advisory panel, appoints new members critical of COVID-19 vaccines, sparking concerns over potential rollback of vaccination recommendations.
BioNTech to acquire German rival CureVac in a $1.25B all-stock deal, bolstering its mRNA capabilities.
UK economy contracts in April due to tariff impact, raising concerns over growth and government targets.
U.S. Health Secretary Robert F. Kennedy Jr. dismisses CDC vaccine advisory panel, appoints new members critical of COVID-19 vaccines, sparking concerns over potential rollback of vaccination recommendations.